- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02893384
Local Anesthetic for Total Mastectomy Surgery
Analgesic Effects of Local Anesthetic Serratus Plane Infiltration for Total Mastectomy Surgery: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mastectomy is associated with significant acute postoperative pain. It has been shown that inadequately managed post-mastectomy pain in breast cancer patients can have detrimental physiological, psycho-behavioural, recovery and healthcare utilization consequences. Most significantly, acute postoperative pain appears to be a substantial risk factor for progression to chronic post-surgical pain (CPSP), occurring in up to 68% of patients,, with higher severity of acute pain being linked with a greater progression to CPSP. A multimodal analgesic approach is the optimal method of reducing the risk of progression to CPSP, and there are a number of analgesic techniques that can be used to reduce the incidence of acute postoperative pain. Of the analgesic techniques used, the most common are multimodal systemic analgesia, thoracic paravertebral blockade, thoracic epidural analgesia, local anesthetic wound infiltration, and more recently pecs blocks and serratus plane blocks. The former three techniques are all associated with drawbacks including technical challenges, high risk of adverse effects, and limited evidence to minimize the progression to CPSP states, whilst local anesthetic wound infiltration has highly variable pain outcomes. Therefore, an alternative, safer, and more effective technique would be ideal.
Local infiltration analgesia (LIA) techniques have been demonstrated to be efficacious in joint surgery, whilst injection of local anesthesia in the serratus plane to target some of the intercostal and pectoral nerves may have some benefit in mastectomy surgery. However, nobody has yet performed LIA around these nerves in breast surgery, and the investigators feel that this has enormous potential.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Undergoing elective or urgent, primary, unilateral mastectomy with or without axillary lymph node dissection
- ASA-PS I-III
- 18-85 years of age, inclusive
- 50-100 kg, inclusive
- BMI 18 - 40
Exclusion Criteria:
- Bilateral mastectomy surgery
- Revision mastectomy surgery
- Inability or refusal to provide informed consent
- Chronic pain state
- Neuropathic pain
- Opioid dependence
- Allergy to local anesthesia
- Allergy to opioids
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Local Anesthetic Injection
The intervention involves injection of local anesthetic (0.25% bupivacaine with 1:200,000 epinephrine) under direct vision in the serratus anterior muscle plane at the end of surgery. Local Anesthetic Injection above the serratus anterior |
This is a quantitative pilot study assessing whether a new technique of local anesthesia injection during mastectomy surgery gives better pain outcomes than the standard methods.
Patients who meet inclusion criteria will be invited to partake and all patients will have the injection technique.
These patients will then be monitored for pain outcomes up to 7 days following the surgery and the results compared with historical results from patients who have already had the surgery.
Other Names:
|
NO_INTERVENTION: Control Arm
Retrospective control group who have not had the new injection technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in subjective Visual Analogue Scale (VAS)
Time Frame: 7 days after surgery
|
The visual analogue scale is administered at different time points
|
7 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Adverse Event Outcomes
Time Frame: 72 hours post operatively
|
The visual analogue scale is administered at different time points
|
72 hours post operatively
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-5729
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Pain
-
Mayo ClinicNew Health InternationalCompletedCyclical Breast PainUnited States
-
Washington University School of MedicineCompletedBreast Cancer | Breast Cancer Female | Cancer of BreastUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Spaulding Rehabilitation HospitalCompletedBreast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast CancerUnited States
-
Cairo UniversityRecruitingNeck Pain | Breast FeedingEgypt
-
Kutahya Health Sciences UniversityVrije Universiteit BrusselCompletedBreast Cancer | Chronic Pain | Cancer PainTurkey
-
Aretaieion University HospitalCompletedPain, Postoperative | Breast Cancer | Breast Neoplasms | Chronic Pain | Anesthesia | Breast Cancer Female | Pain Syndrome | Breast Pain | Breast Soft Tissue NeoplasmGreece, Cyprus
-
University of ValenciaCompletedPostoperative Pain | Chronic Post Operative Pain | Breast Tumor | Locoregional Anesthesia | Breast PainSpain
-
Mayo ClinicTerminatedBreast Pain | Non-cyclical Mastalgia | Surgical Scar-Related Breast PainUnited States
-
Lynn HenryCompletedPain | Breast CancerUnited States
-
Nova Scotia Health AuthorityCompletedBreast Cancer Surgery | Post Operative PainCanada
Clinical Trials on Local Anesthetic Injection above the serratus anterior
-
Moroccan Society of SurgeryRecruitingPain, Postoperative | Breast Neoplasms | Pain, Chronic | Post-Mastectomy Chronic Pain SyndromeMorocco
-
Lawson Health Research InstituteRecruitingPain Management | Video Assisted Thoracic Surgery (VATS)Canada
-
Wake Forest University Health SciencesRecruitingChronic Plantar FasciitisUnited States
-
Mustafa Kemal UniversityRecruitingEfficacy of Dextrose Prolotherapy in Myofascial Pain SyndromeTurkey
-
Feng XiaCompletedBreast Cancer | Chronic Pain | Serratus Plane BlockChina
-
Hôpital du ValaisUniversity of Lausanne HospitalsCompleted
-
Rhode Island HospitalNot yet recruitingOpioid Use | Rib Fractures | Regional Anesthesia | Pain AcuteUnited States
-
University of BrasiliaSuspendedChronic Pain | Hip OsteoarthritisBrazil
-
Zagazig UniversityRecruiting
-
New York Presbyterian Brooklyn Methodist HospitalCompletedSerratus Anterior Plane Block | Transversus Thoracis Plane Block | Subcutaneous ICDUnited States